Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial.
Saved in:
| Title: | Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial. |
|---|---|
| Authors: | Waheed MT; Department of Surgery, City of Hope National Medical Center, Duarte, CA, USA., Ruel N; Computation and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA, USA., Whelan RL; Department of Surgery, Northwell Health, New York, NY, USA., Fakih M; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA., Fong Y; Department of Surgery, City of Hope National Medical Center, Duarte, CA, USA., Deperalta D; Department of Surgery, Northwell Health, New York, NY, USA., Merchea A; Department of Surgery, Mayo Clinic, Jacksonville, FL, USA., Sun V; Department of Population Sciences, City of Hope National Medical Center, Duarte, CA, USA., Krouse R; Department of Surgery, University of Pennsylvania, Philadelphia, PA, USA., Dellinger TH; Department of Surgery, City of Hope National Medical Center, Duarte, CA, USA. tdellinger@coh.org., Raoof M; Department of Surgery, City of Hope National Medical Center, Duarte, CA, USA. mraoof@coh.org. |
| Source: | Annals of surgical oncology [Ann Surg Oncol] 2024 Nov; Vol. 31 (12), pp. 7998-8007. Date of Electronic Publication: 2024 Sep 13. |
| Publication Type: | Journal Article; Clinical Trial, Phase I |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
